<![CDATA[Centocor Inc. | Company News & Executive Profiles | BNET]]> en-us <![CDATA[Ustekinumab approval delayed by FDA]]> Sun, 01 Feb 2009 23:59:59 -0800 <![CDATA[Seminar in advanced rheumatology: selected proceedings of a live symposium held March, 2008 bulletin of the NYU hospital for joint diseases]]> Mon, 01 Sep 2008 23:59:59 -0700 AMGN BMY DNA AMGN,BMY,DNA <![CDATA[Research and Markets: Available Now: Thought Leader Insight & Analysis: Psoriasis]]> Wed, 28 May 2008 23:59:59 -0700 <![CDATA[Centocor joins its parent company in blogosphere]]> Tue, 01 Apr 2008 23:59:59 -0700 <![CDATA[Centocor and ustekinumab]]> Tue, 01 Apr 2008 23:59:59 -0700 <![CDATA[Psunrise: prospective study using remicade in psoriasis patients with an inadequate response to etanercept]]> Tue, 01 Apr 2008 23:59:59 -0700 <![CDATA[Endo acts quickly to name CEO: David Holveck]]> Thu, 13 Mar 2008 23:59:59 -0700 <![CDATA[Endo Pharmaceuticals Names David P. Holveck President and Chief Executive Officer]]> Wed, 12 Mar 2008 23:59:59 -0700 ENDP JNJ ENDP,JNJ <![CDATA[MEASURING THE SIGNAL]]> Sat, 01 Mar 2008 23:59:59 -0800 <![CDATA[Prospective study using remicade in psoriasis patients with an inadequate response to etanercept]]> Sat, 01 Mar 2008 23:59:59 -0800